Significant reduction in mortality with streptokinase given 7-24 hours after pain onset.

Eitemau Tebyg

• Effects of streptokinase in patients presenting within 6 hours of prolonged chest pain with ST segment depression.
  gan: Collins, R, et al.
  Cyhoeddwyd: (1995)
• ISIS-3 and GISSI-2: no survival advantage with tissue plasminogen activator over streptokinase, but a significant excess of strokes with tissue plasminogen activator in both trials.
  gan: Collins, R, et al.
  Cyhoeddwyd: (1993)
• ISIS-2 - A LARGE RANDOMIZED TRIAL OF INTRAVENOUS STREPTOKINASE AND ORAL ASPIRIN IN ACUTE MYOCARDIAL-INFARCTION
  gan: Collins, R, et al.
  Cyhoeddwyd: (1989)
• Holter monitoring of ventricular arrhythmias in a randomised, controlled study of intravenous streptokinase in acute myocardial infarction.
  gan: Alexopoulos, D, et al.
  Cyhoeddwyd: (1991)
• RANDOMIZED TRIAL OF HIGH-DOSE INTRAVENOUS STREPTOKINASE, OF ORAL ASPIRIN, AND OF INTRAVENOUS HEPARIN IN ACUTE MYOCARDIAL-INFARCTION
  gan: Collins, R, et al.
  Cyhoeddwyd: (1987)